BD buys infection surveillance firm
This article was originally published in Clinica
BD Diagnostics has bolstered its portfolio of products designed to prevent and control infectious diseases by purchasing Austin, Texas-based ICPA, a specialist in infection surveillance systems. The acquisition provides BD with the AICE software system, which is designed to track and monitor emerging infection issues among patients and healthcare workers in hospitals. The software continuously tracks emerging drug-resistant organisms and the incidence of healthcare-associated infections, and generates alerts that signal critical risk of infections. BD provides a range of products for infection control, including rapid assays for detecting the presence of infectious organisms. Financial terms of the deal were not disclosed.